Key technology: Make good use of algorithms to construct an optimized AI intelligent assisted interpretation model
In order to enhance the credibility of the platform, Neurobit Technologies Co., Ltd. actively cooperates with Sanzong, Haoming and other medical institutions to collect cases, and record and mark the data, including the age, gender, vision, degree of myopia, and axial length of the suitable cases. After collation and analysis, the number reached more than a thousand.
After having the data, it is also necessary to establish a credible algorithm. Neuron Technology sorts out the reference data, knowledge base, rules and guidelines, etc., and integrates the inference engine, equation, analysis engine, etc. to create a medical device software (SaMD) Algorithm to build an optimized AI intelligent assisted interpretation model. In addition, a database is also established, different analysis modules are created, and risk scores are graded to facilitate future judgments; at the same time, a network analysis platform is constructed to provide disease analysis for the input of new subject data by comparing it with the database. and treatment recommendations.
Application scenario: Let the model find the appropriate treatment for children
Neurobit Technologies Co., Ltd. hopes that after the birth of the school-age children's myopia risk analysis and tracking AI platform, every child with myopia can get the results of the child's eye refractive development by inputting a series of inspection values such as the child's vision and optometry. relevant information. Not only can it help parents and doctors track the development of myopia in children, but it can also use data AI analysis to assist parents and doctors in evaluating the effectiveness of children's myopia control. Among the many treatment methods such as contact lenses, the most suitable method is suggested in a scientific way.
Looking to the future: Bringing services to every corner, improving medical quality and reducing social medical costs
We are committed to bringing this platform from Taiwan to the global stage, and spreading it from clinics, hospitals and other fields to multiple fields such as clinics and optical shops, so that not only more people can enjoy better medical quality, but also Simultaneously reducing the medical cost of the society can be said to serve multiple purposes.
Executive team
Travis Yang, Ph.D.
CEO of Neurobit Technologies Co., Ltd.

Jim Huang, M.S.
CTO of Neurobit Technologies Co., Ltd.

Roger Chen, EMBA
COO of Neurobit Technologies Co., Ltd.

Ching-Fu Wang, Ph.D.
CIO of Neurobit Technologies Co., Ltd

Clinical consultant
Ke-Hung Chien, MD/Ph.D.
Director of Tri-Service General Hospital / Department of Ophthalmology / Vision Care

Lung-Chi Lee, MD
Attending Physician of Tri-Service General Hospital/Department of Ophthalmology/Department of Pediatric Ophthalmology


Be aware of your child's risk of developing myopia
Artificial intelligence guides the most appropriate diagnosis and treatment for myopic school children